With Asia’s explosive growth in technological development coupled with strong economical sentiments from business quarters across the globe, participation in the future begins here – In the epicentre of innovation.
Enabling Companies
of Tomorrow
Round Table explores and enables revolutionising technologies in a number of sectors including medical tech, biotech, life sciences, information technology, green tech, agricultural tech and more.
Mediland Pharm Limited (ASX:MPH) is a leading retailer of health and well-being products with retail operations located in Sydney, Melbourne and the Gold Coast within Australia and Auckland in New Zealand.
MPH specialises in and offers a broad range of high-quality health, well-being and skin care supplements, based on quality ingredients mainly sourced from the clean, green land and water for, which Australia is renowned, including a wide range of luxury products, including; opal and pink diamond jewellery pieces, souvenirs and gifts, luxurious bedding and a fashionable range of rugs.
On the final week of Feb 2019, MPH commenced trading at the IPO price of A$0.20 and peaked to A$0.45 in April 2019.
Reclaims Global Limited (SGX: NEX) is an eco-friendly construction service provider publicly listed on the Singaporean stock exchange (SGX). NEX specialises in recycling construction and demolition waste, customising excavation solutions and operating fleet management through environmentally-friendly methods.
Advanced Human Imaging Limited (ASX:AHI) focuses on developing a revolutionary technology that uses captured images to measure health ailments and more. Leveraging on the power of computer vision, machine learning and patented algorithms, this technology delivers a staggering 97% accuracy with a repeatability of 98%.
From consumer-facing to industrial tech, this health measurement technology has the potential to be a crucial integrated system in the frontiers of tomorrow's technological developments, spelling a largely untapped economic potential in the future.
Osteopore is a medical technology company in Singapore that is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Its proprietary technologies allow for the development of biostructures which are synthetic biologically active tissue engineered products for the restoration of the human skeleton; has won multiple awards worldwide for its innovation in medical tech, and has also accumulated a long track record of successful 10-year clinical outcomes.
Equipped with an extremely valuable product that will revolutionise the medical industry for years to come, Osteopore is aiming to bring this technology to some of the world's best medical institutions, and eventually to the rest of the globe.
Osteopore is targeting its IPO in Australia in September 2019.
ML is a brand new one-stop medical wellness destination in Malaysia & Singapore that provides a broad range of medical wellness facilities in Malaysia & Singapore, starting with post-partum care, offering modernised medical wellness facilities and postnatal care.
In the coming years, ML will gradually offer additional care facilities, namely paediatric, physiotherapy, dental, chiropractic, dental and much more in a single facility as a one-stop medical wellness destination.
SRC is a well-known seafood retail and processing company based in Australia. It sources and processes produce from some of Australia's finest farms for domestic and international consumption.
An aquaponics company specialising in growing high quality organic fish and vegetable produce through its patent pending aquaponics systems.
This proprietary system combines the cutting-edge aquaponics mechanisms with the use of biotechnology, enabling higher density farming on smaller land plots. The modular-type configuration of this system also allows vegetable produce to be pesticide and synthetic fertiliser free, making it a very healthy, sustainable and profitable venture.
LSC focuses on Stem Cell and Regenerative Medicine, developing therapeutic stem cell platform technologies using viable discoveries of stem cell research and developments producing the forefront of new generation treatment using Mesenchymal Stem Cells (MSC) as the platform of the stem cell technology which capitalises its product candidates for wellness and orthopedic diseases.
Its products are developed to reconstruct a patient’s cartilage for rapid-onset pain relief and restored function with a non-surgical procedure, of which are currently being evaluated in the largest and first prospectively designed, randomised Phase 2 clinical trial in Malaysia.
LSC currently has issued patents and patent applications in United States & Malaysia. The unique potential of MSC generation has the ability to achieve economic manufacture at commercial scale using state-of-the-art cleanroom laboratories.
Description will be made available soon.
MOV is an established integrated seafood player specialising in farming, processing and exporting of black tiger shrimps across Asia Pacific, producing its own specific pathogen free breeding shrimp stock which are fed a specially formulated feed to ensure a consistent high yield, high quality produce on every batch of its produce.
Description will be made available soon.
NXG is a Korean-based manufacturer and distributor of smart construction materials across the globe, while maintaining proprietary oversight over the entire manufacturing process.